FDA Recall D-0133-2024

Cardinal Health Inc. · Dublin, OH

Class I — life-threatening Ongoing 926 days on record

Highest impact — Class I recall — FDA determination of strong likelihood of serious adverse health consequence or death. Distribution is nationwide and the recall remains in progress.

Product

LEADER brand Lubricant Eye Drops (Carboxymethylcellulose Sodium, 0.5%); 0.5 FL OZ (15 mL) dropper bottles, Sterile, Distributed By Cardinal Health, Dublin, Ohio 43017. Made in India NDC: 70000-0090-1

Lot / code: ALL LOTS

Quantity: 119,871 bottles

Reason for recall

Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

Recall record

Recall number: D-0133-2024
Classification: Class I
Status: Ongoing
Voluntary or mandated: Voluntary: Firm initiated
Firm notification: Press Release
Distribution: Nationwide in the USA
Recall initiated: 2023-10-31
Classified by FDA Center: 2023-12-01
FDA published: 2023-11-29
Recalling firm: Cardinal Health Inc.
Firm location: Dublin, OH

Drug identification

Brand name(s): LUBRICANT DROPS
Generic name(s): CARBOXYMETHYLCELLULOSE SODIUM
Manufacturer(s): CARDINAL HEALTH 110, LLC. DBA LEADER
NDC(s): 70000-0090
Route(s): OPHTHALMIC

Operational response

A Class I recall indicates a strong likelihood of serious adverse health consequence or death. Pull affected lots from active dispensing immediately. Segregate inventory in a marked, locked location pending destruction or return. If product has already been dispensed, identify affected patients and contact them by your standard recall-notification protocol.

For the official FDA enforcement record, see FDA's Recall Search.

‹ All recalls